Hosted on MSN10m
Hims & Hers can't sell off-brand Ozempic forever, but it can still sell these weight-loss medsHowever, when drugs are in shortage, the U.S. Food and Drug Administration (FDA) doesn’t consider them commercially available ...
Hims & Hers is stopping its sales of an alternative to blockbuster weight-loss drugs Wegovy and Ozempic. That follows the U.S ...
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 27.6% in the afternoon session after the company delivered mixed fourth-quarter 2024 results: It added fewer customers than expected, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback